Rosemont is the only dedicated globally integrated oral liquids platform with a 56 year track record of successfully developing and commercialising complex oral liquid medicines for patients with swallowing difficulties and dysphagia, seeing a 231% growth in sales and 45% growth in workforce in recent years.
